PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Projects
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Pricing and Market Access
Events
Reports
Premium Insights
Excellence Awards
Magazine
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Accelerating Clinical Trials
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Projects
Latest
Magazine: The journey of first generics
Cybersecurity in pharma: Securing the future
ASCO 2023: Keytruda becomes a new option in perioperative NSCLC
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
ASCO 2023: Ellipses Pharma advances plans for RET inhibitor following encouraging results
ASCO 2023: Moderna and MSD’s vaccine/IO combo reduces chances of melanoma spreading
Oragenics secures CQDM funding for Covid-19 vaccine antigen development
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Cybersecurity in pharma: Securing the future
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
University of Sydney will use AI to boost cancer drug research
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Who’s investing where? Private equity deal activity in the pharmaceutical industry in Europe decreased by 29% in Q1 2023
Who’s acquiring who? M&A activity in the pharmaceutical industry in Japan decreased by 5% in Q1 2023
Who’s investing where? Private equity deal activity in the pharmaceutical industry in The US decreased by 27% in Q1 2023
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Latest
The European Reference Genome Atlas Initiative: Advancing understanding of European biodiversity
Communications in life sciences: Uncovering the Unlocked survey results
Medicines adherence: Overcoming pharma’s biggest barrier to treatment success
Events
Reports
Premium Insights
PT
February 10, 2021
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment – Issues and Solutions
By
IndiaProduction
IndiaProduction
Share this article
Recommended Reports
Reports
Canada - Healthcare, Regulatory and Reimbursement Landscape
GlobalData
Reports
New Zealand - Healthcare, Regulatory and Reimbursement Landscape
GlobalData
View all
IndiaProduction
